1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in the United Kingdom, May 2019

Mental Health Analysis & Statistics in the United Kingdom, May 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

All regions

1-30 of about 100 reports

University of Edinburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Edinburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2018

SummaryUniversity of Edinburgh (UE) is an educational service provider that offers undergraduate and postgraduate programs.The university offers courses in the areas of accounting, art, business, chemistry, ...

  • Industries : Pathology
  • Countries : United Kingdom
University of Liverpool - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Liverpool - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2018

SummaryUniversity of Liverpool is an academic and research university that provides undergraduate, postgraduate, and online programs.The university owns scientific teaching laboratories.It offers services ...

  • Industries : Therapy, Pathology
  • Countries : United Kingdom
Heptares Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Heptares Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryHeptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs.The company develops drugs for targeting G-protein-coupled receptors ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United Kingdom
Cytox Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cytox Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryCytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services.The company offers development of tests to identify individuals at risk of cognitive ...

  • Industries : Mental Health, Pharmaceutical, Pathology
  • Countries : United Kingdom
Mission Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mission Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryMission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United Kingdom, United States
Cytox Ltd - Medical Equipment - Deals and Alliances Profile

Cytox Ltd - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryCytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services.The company offers development of tests to identify individuals at risk of cognitive ...

  • Industries : Mental Health, Medical Device, Medical Supply, Pathology
  • Countries : United Kingdom
University of Sheffield - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Sheffield - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryUniversity of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes.The university offers courses in various ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United Kingdom
Cantabio Pharmaceuticals Inc (CTBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cantabio Pharmaceuticals Inc (CTBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryCantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and ...

  • Industries : Pharmaceutical, Mental Health, Pathology
  • Countries : United Kingdom, United States
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • $ 3500 - $ 2800 - Get 20% off now!
  • Company report
  • October 2018

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018SummaryGlycogen Synthase Kinase 3 Beta (Serine/Threonine Protein ...

  • Industries : Therapy, Pharmaceutical, Pathology, Cancer
  • Countries : United States, World, United Kingdom
IXICO Plc (IXI) - Medical Equipment - Deals and Alliances Profile

IXICO Plc (IXI) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryIXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs.The company ...

  • Industries : Medical Device, Medical Supply, Mental Health
  • Countries : World, United Kingdom, United States
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2018

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2018

  • $ 3500 - $ 2800 - Get 20% off now!
  • Company report
  • October 2018

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer, Mental Health, Pharmaceutical, Therapy
  • Countries : United States, World, United Kingdom
IXICO Plc (IXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

IXICO Plc (IXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryIXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs.The company ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : United Kingdom, World
SomaLogic Inc - Product Pipeline Analysis, 2018 Update

SomaLogic Inc - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummarySomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan ...

  • Industries : Pathology, Mental Health, Diagnostics, Cancer, Chronic Disease
  • Countries : United States, United Kingdom
Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027

  • $ 3995 - $ 3196 - Get 20% off now!
  • Industry report
  • July 2018

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027SummaryAmyotrophic Lateral Sclerosis (ALS) is often referred to as "Lou Gehrig’s Disease" after the famous baseball player who was diagnosed ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, World, Germany, United Kingdom
Parkinson’s Disease: Epidemiology Forecast to 2026

Parkinson’s Disease: Epidemiology Forecast to 2026

  • $ 3995 - $ 3196 - Get 20% off now!
  • Industry report
  • May 2018

Parkinson’s Disease: Epidemiology Forecast to 2026SummaryParkinson’s disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s disease, ...

  • Industries : Mental Health, Pathology
  • Countries : United States, United Kingdom, Japan, Spain, Germany
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H1 2018

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H1 2018

  • $ 3500
  • Company report
  • April 2018

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H1 2018SummaryGlycogen Synthase Kinase 3 Beta (Serine/Threonine Protein ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : World, United States, United Kingdom
Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018

  • $ 3500
  • Company report
  • April 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018 ...

  • Industries : Pathology, Therapy, Pharmaceutical, Mental Health
  • Countries : World, United Kingdom, United States, Australia, Australasia
Drug Overview: Latuda

Drug Overview: Latuda

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom, Italy, Japan, European Union, United States, Germany, Spain
Learning Disability, Mental Health & Substance Abuse Facilities in the UK - Industry Market Research Report

Learning Disability, Mental Health & Substance Abuse Facilities in the UK - Industry Market Research Report

  • $ 680
  • Industry report
  • October 2017

Healthier prospects: Despite pressure on prices, rising demand will support growthAbstractLearning Disability, Mental Health & Substance Abuse Facilities in the UKOperators in this industry provide residential ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • October 2017

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026SummaryAlzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Spain, Japan, Italy, Germany, France, United Kingdom
Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bipola ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Attention Deficit Hyperactivity Disorder patients study in a new report ‘Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Depression patients study in a new report ‘Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Global Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on